DCF Advisers’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $867K | Hold |
62,029
| – | – | 0.4% | 56 |
|
|
2025
Q1 | $836K | Buy |
62,029
+32,279
| +109% | +$435K | 0.4% | 57 |
|
|
2024
Q4 | $570K | Buy |
29,750
+15,250
| +105% | +$292K | 0.28% | 64 |
|
|
2024
Q3 | $330K | Sell |
14,500
-3,250
| -18% | -$73.9K | 0.13% | 69 |
|
|
2024
Q2 | $231K | Buy |
17,750
+3,250
| +22% | +$42.3K | 0.12% | 78 |
|
|
2024
Q1 | $254K | Buy |
14,500
+5,000
| +53% | +$87.6K | 0.13% | 65 |
|
|
2023
Q4 | $207K | Sell |
9,500
-4,000
| -30% | -$87.1K | 0.11% | 63 |
|
|
2023
Q3 | $207K | Sell |
13,500
-5,500
| -29% | -$84.4K | 0.11% | 66 |
|
|
2023
Q2 | $452K | Buy |
+19,000
| New | +$452K | 0.24% | 55 |
|